Scarica l'app Stockscreener
4.68
2.30%
-0.11
Dopo l'orario di chiusura:
4.68
Precedente Chiudi:
$4.79
Aprire:
$4.71
Volume 24 ore:
3.37M
Relative Volume:
0.67
Capitalizzazione di mercato:
$2.49B
Reddito:
$2.21B
Utile/perdita netta:
$-56.94M
Rapporto P/E:
-41.64
EPS:
-0.1124
Flusso di cassa netto:
$54.54M
1 W Prestazione:
+2.18%
1M Prestazione:
+0.43%
6M Prestazione:
+117.67%
1 anno Prestazione:
+67.14%
Intervallo 1D:
$4.61
$4.76
Intervallo di 1 settimana:
$4.61
$5.21
Portata 52W:
$1.58
$5.59
Clover Health Investments Corp Stock (CLOV) Company Profile
Nome
Clover Health Investments Corp
Settore
Industria
Telefono
(201) 432-2133
Indirizzo
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
4.68 | 2.49B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
406.67 | 365.02B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
92.58 | 118.41B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
428.43 | 92.91B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
298.81 | 78.96B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
432.20 | 51.90B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-10 | Iniziato | Deutsche Bank | Buy |
| 2024-12-17 | Iniziato | Craig Hallum | Buy |
| 2024-10-07 | Iniziato | UBS | Neutral |
| 2022-02-02 | Iniziato | Canaccord Genuity | Buy |
| 2022-02-02 | Aggiornamento | Cowen | Underperform → Market Perform |
| 2022-01-19 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-01-10 | Ripresa | Citigroup | Neutral |
| 2022-01-07 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Iniziato | Cowen | Underperform |
| 2021-09-02 | Ripresa | Citigroup | Neutral |
| 2021-07-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-02-02 | Iniziato | Citigroup | Buy |
| 2021-02-01 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Clover Health Investments Corp Borsa (CLOV) Ultime notizie
Clover Health: Star Plan Rating Buoys ItWhy I'm (Cautiously) Long-Term Bullish (CLOV) - Seeking Alpha
Discover Power Solutions International And 2 More Leading Growth Stocks With Insider Ownership - Simply Wall Street
Form 144 Clover Health Investments For: 11 October By Investing.com - Investing.com South Africa
Form 144 Clover Health Investments For: 11 October By Investing.com - Investing.com Nigeria
Clover Health Investments (CLOV) Is Up 9.4% After Securing 5-Star PPO CMS Rating For 2027 - Yahoo Finance
Clover Health (CLOV) Stock Looks In Line Despite 5 Star Medicare News - Yahoo! Finance Canada
Why Is Clover Health (CLOV) Stock Soaring Today - Yahoo Finance
Clover Health Stock Pops: What's Happening? - Benzinga
Clover Health Investments (NASDAQ:CLOV) Shares Gap UpStill a Buy? - MarketBeat
Why Is Clover Health (CLOV) Stock Soaring Today - Barchart.com
Is Clover Health Stock Too Dependent On One Group Of Members? - Yahoo Finance
Clover Health Medicare Advantage PPO Plans Earn 5-Star Rating; HMO at 4.5 Stars - TradingView
Global Insurtech Market Size, Share, Trends, and Forecast to 2035 | AI, Cloud, and Automation Drive 41.45% CAGR, Creating a USD 638 Billion Opportunity - GlobeNewswire Inc.
Clover Health (CLOV) Medicare Advantage PPO Plans Earn 5-Star CM - GuruFocus
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027 - GlobeNewswire Inc.
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027 - Moomoo
Clover Health (CLOV) Shares Rise 8.5% After Medicare Advantage S - GuruFocus
Clover Health sets results date. Deutsche Bank sets USD 6.00 target for Clover Health stock - AD HOC NEWS
Clover Health to present at Jefferies and Deutsche Bank conferences - scanx.trade
Clover Health (CLOV) CEO Jamie Reynoso Sells 2,006 Shares as Sto - GuruFocus
Clover Health Medicare Advantage CEO Jamie Reynoso sells $9,287 in stock - Investing.com Nigeria
Form 4 Clover Health Investments Corp For: 7 October By Investing.com - Investing.com India
Clover Health Q3FY26 Results: Earnings call set for Nov 4, 2026 - scanx.trade
Under a trading plan, Jamie L. Reynoso sells Clover Health (CLOV) shares at $4.63 on average. - Stock Titan
Officer Jamie Reynoso plans to sell 2,006 Clover Health (CLOV) shares. - Stock Titan
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026 - The Manila Times
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026 - Moomoo
Clover Health CEO, Medicare Advantage, sells $38,675 of CLOV shares By Investing.com - Investing.com Nigeria
Form 4 Clover Health Investments Corp For: 6 October By Investing.com - Investing.com Canada
Clover Health CEO, Medicare Advantage, sells $38,675 of CLOV shares By Investing.com - Investing.com Canada
Form 4 Clover Health Investments Corp For: 6 October By Investing.com - Investing.com UK
An executive sells 8,750 Clover Health (CLOV) shares in a mandatory sale to cover taxes. - Stock Titan
An officer proposes selling 8,706 Clover Health (CLOV) shares to cover stock-award taxes. - Stock Titan
Why is Clover Health (NASDAQ:CLOV) stock in focus as Medicare plans roll out? - Kalkine Media
What Is Clover Health (NASDAQ:CLOV) Offering As Annual Enrollment Nears? - Kalkine Media
Have Insiders Sold Clover Health Investments Shares Recently? - Moomoo
Clover Health Investments (CLOV) Unveils 2027 Medicare Plans, Is The Stock Still Cheap? - Yahoo Finance
Clover Health Investments (NASDAQ:CLOV) CEO Sells 318,806 Shares of Company Stock - MarketBeat
Clover Health Director Robert G. Torricelli Granted 12,481 RSUs in September 2026 - Kalkine Media
Clover Health Investments, Corp. (CLOV) stock price, news, quote and history - Yahoo Finance UK
Clover Health Investments, Corp. (CLOV) Options Chain - Yahoo! Finance Canada
To cover vesting taxes, Andrew Toy proposes selling 309,558 Clover Health (CLOV) shares. - Stock Titan
Clover Health Investments, Corp. (CLOV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Robert G. Torricelli Files Initial Ownership Disclosure as Clover Health Director - Kalkine Media
Clover Health Investments, Corp. (CLOV) stock price, news, quote and history - Yahoo Finance UK
Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value - The Manila Times
Up to $400 in rewards for eligible healthy activities feature in Clover Health’s 2027 Medicare plans. - Stock Titan
Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value - Yahoo Finance
Total common shares outstanding of Clover Health Investments Corp. Class A – HAN:7QD - TradingView
Why Did Clover Health (NASDAQ:CLOV) Add Two New Board Members? - Kalkine Media
Clover Health Investments Corp Azioni (CLOV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clover Health Investments Corp Azioni (CLOV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| JAMIE REYNOSO | Officer |
Oct 07 '26 |
Proposed Sale |
4.60 |
2,006 |
9,228 |
0 |
| Jamie Reynoso | Officer |
Oct 05 '26 |
Proposed Sale |
4.68 |
8,706 |
40,744 |
0 |
| Reynoso Jamie L. | CEO, Medicare Advantage |
Oct 05 '26 |
Sale |
4.42 |
8,750 |
38,675 |
2,794,696 |
| Toy Andrew | Chief Executive Officer |
Oct 01 '26 |
Sale |
4.19 |
318,806 |
1,335,797 |
9,140,510 |
| Andrew Toy | Officer |
Oct 01 '26 |
Proposed Sale |
4.23 |
309,558 |
1,309,430 |
0 |
| BRADY PRIEST | Former Officer |
Sep 24 '26 |
Proposed Sale |
4.46 |
141,418 |
631,163 |
0 |
| Reynoso Jamie L. | CEO, Medicare Advantage |
Sep 17 '26 |
Sale |
4.56 |
1,921 |
8,760 |
2,803,446 |
| JAMIE REYNOSO | Officer |
Sep 17 '26 |
Proposed Sale |
4.56 |
1,921 |
8,760 |
0 |
| Joseph Frank Oldakowski | Officer |
Sep 16 '26 |
Proposed Sale |
4.64 |
3,170 |
14,709 |
0 |
| OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER |
Sep 16 '26 |
Sale |
4.64 |
3,170 |
14,709 |
275,897 |
1.38%
1.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):